CANCIDAS
Traitement de l'aspergillose invasive chez les patients réfractaires ou intolérants à d'autres traitements (l'amphotéricine B, …
Additional information from the official database
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
PRC
|
70.0 MG | Substance | Wirkstoff (Principe actif) |
|
PRC
|
- | Substance | WIZUS |
|
PRC
|
- | Substance | HNIDK |
|
PRC
|
- | Substance | HNIDK |
|
PRC
|
- | Substance | HNIDK |
|
PRC
|
- | Substance | HNIDK |
|
PRC
|
- | Substance | HBESI |
6005 Luzern